AR062307A1 - MILNACIPRAN PAREL TREATMENT OF FATIGES ASSOCIATED WITH THE FIBROMALGIA SYNDROME - Google Patents
MILNACIPRAN PAREL TREATMENT OF FATIGES ASSOCIATED WITH THE FIBROMALGIA SYNDROMEInfo
- Publication number
- AR062307A1 AR062307A1 ARP070103528A ARP070103528A AR062307A1 AR 062307 A1 AR062307 A1 AR 062307A1 AR P070103528 A ARP070103528 A AR P070103528A AR P070103528 A ARP070103528 A AR P070103528A AR 062307 A1 AR062307 A1 AR 062307A1
- Authority
- AR
- Argentina
- Prior art keywords
- milnacipran
- treatment
- fibromalgia
- fatiges
- parel
- Prior art date
Links
- GJJFMKBJSRMPLA-HIFRSBDPSA-N (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-1-cyclopropanecarboxamide Chemical compound C=1C=CC=CC=1[C@@]1(C(=O)N(CC)CC)C[C@@H]1CN GJJFMKBJSRMPLA-HIFRSBDPSA-N 0.000 title abstract 3
- 229960000600 milnacipran Drugs 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title 1
- 206010016256 fatigue Diseases 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 238000011866 long-term treatment Methods 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Métodos para el tratamiento de fatigas asociadas con fibromialgia mediante la administracion de altas dosis de milnacipran (más de 125 mg), a pacientes que sufran de fatigas. Asimismo, se proveen los métodos para el tratamiento a largo plazo de fatigas asociadas con FMS a través de la administracion de milnacipran a un paciente que sufra de estas fatigas.Methods for the treatment of fatigue associated with fibromyalgia by administering high doses of milnacipran (more than 125 mg), to patients suffering from fatigue. Also, methods for the long-term treatment of fatigue associated with FMS are provided through the administration of milnacipran to a patient suffering from these fatigue.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83685706P | 2006-08-09 | 2006-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062307A1 true AR062307A1 (en) | 2008-10-29 |
Family
ID=39929395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070103528A AR062307A1 (en) | 2006-08-09 | 2007-08-09 | MILNACIPRAN PAREL TREATMENT OF FATIGES ASSOCIATED WITH THE FIBROMALGIA SYNDROME |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR062307A1 (en) |
| TW (1) | TW200814990A (en) |
-
2007
- 2007-08-08 TW TW96129184A patent/TW200814990A/en unknown
- 2007-08-09 AR ARP070103528A patent/AR062307A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200814990A (en) | 2008-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20110100A7 (en) | PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPIC HEPATIC FUNCTION | |
| ECSP077368A (en) | DOSE DISPLAY MECHANISM FOR A DEVICE FOR DRUG ADMINISTRATION | |
| MX367667B (en) | Dosage regimen of an s1p receptor agonist. | |
| AR057946A1 (en) | FORMULATION OF SUSTAINED RELEASE ZONISAMIDE | |
| UY30901A (en) | NEW METHODS | |
| ECSP10010106A (en) | TRANS-CLOMPHENE FOR METABOLIC SYNDROME | |
| MX2009013989A (en) | Combination therapy for depression. | |
| CO6390117A2 (en) | DOSAGE REGIME FOR AN S1P RECEIVER AGONIST | |
| MX2009010289A (en) | COMPOSITIONS FOR NASAL ADMINISTRATION. | |
| UY35624A (en) | USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE | |
| AR058163A1 (en) | EXHALTING DRUGS OF SEXUAL DESIRE THAT INCLUDE DERIVATIVES OF BENZIMIDAZOLONA | |
| AR095338A1 (en) | NON-TOXIC TREATMENT METHOD FOR DRUG ABSTINENCE | |
| CR20110243A (en) | PIRFENIDONE TREATMENT FOR PATIENTS WITH HEPATIC FUNCTION. | |
| MA31720B1 (en) | MILNACIPRAN FOR THE LONG-TERM TREATMENT OF FIBROMYALGIA SYNDROME | |
| BR112013010829A2 (en) | intravenous pharmaceutical composition to provide pain and / or inflammation relief, use and method thereof | |
| AR059357A1 (en) | PHARMACEUTICAL FORMULATIONS | |
| ECSP045493A (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERINE POLYMORPH A | |
| AR073265A1 (en) | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION OF ICTUS OR TRANSITIONAL ISCHEMICAL ATTACK | |
| AR062784A1 (en) | TREATMENT OF THE VERTIGES WITH ACETIL -L- LEUCINA | |
| AR075866A1 (en) | A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL DETERIORATION. USE. PHARMACEUTICAL COMPOSITION | |
| CO5700723A2 (en) | USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY | |
| AR062307A1 (en) | MILNACIPRAN PAREL TREATMENT OF FATIGES ASSOCIATED WITH THE FIBROMALGIA SYNDROME | |
| EA200501565A1 (en) | INTENDED FOR ORAL ADMINISTRATION MEDICINE FORM FOR PROTONE PUMP ANTAGONISTS | |
| CO2022004947A2 (en) | Dosage regimens for the treatment of patients with locally advanced squamous cell carcinoma | |
| MX2009008813A (en) | PHARMACEUTICAL COMPOSITION CONTAINING FLOROGLUCINOL AND PARACETAMOL. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |